|
|
|
| home > white papers > High-tech Packaging for High-tech Medicine - West Pharmaceutical Services, Inc. |
|
|
 WHITE PAPERS |
|
West Pharmaceutical Services, Inc.
|
|
High-tech Packaging for High-tech Medicine
|
|
As more biologics and biosimilars come on to the global pharmaceutical market, they can and will present unique packaging and containment challenges. For materials that are sensitive to glass or that may require larger-dose volumes or custom configurations, cyclic olefin polymers may offer a solution. These novel materials for drug container closure systems can provide a needed alternative to traditional glass containment systems for advanced therapeutics.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Reify Health Raises $220 Million to Eliminate Waiting in Clinical Trials
Reify Health
today announced a $220 million Series C funding round led by Coatue
Management, joined by ICONIQ Growth and Adams Street Partners, as well
as existing investors Sierra Ventures and Battery Ventures.
More info >> |
|
 |
White Papers |
 |
|
Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.
Medpace
Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >> |
|
|
|
